Cargando…
MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy
Aim: Circulating microRNA expression has become a biomarker of cardiovascular disease; however, the association of microRNA expression between circulation and myocardium in hypertrophic cardiomyopathy remains unclear. The present study aimed to find a circulating biomarker correlated not only to myo...
Autores principales: | Huang, Derong, Chen, Zhongxiu, Wang, Jie, Chen, Yucheng, Liu, Daxing, Lin, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954366/ https://www.ncbi.nlm.nih.gov/pubmed/31868204 http://dx.doi.org/10.1042/BSR20191234 |
Ejemplares similares
-
MicroRNA-375: potential cancer suppressor and therapeutic drug
por: Wei, Jiahui, et al.
Publicado: (2021) -
MicroRNA-33a negatively regulates myoblast proliferation by targeting IGF1, follistatin and cyclin D1
por: Li, Xinxin, et al.
Publicado: (2020) -
MicroRNA-197 regulates chondrocyte proliferation, migration, and inflammation in pathogenesis of osteoarthritis by targeting EIF4G2
por: Gao, Shijie, et al.
Publicado: (2020) -
The inhibition of tumor protein p53 by microRNA-151a-3p induced cell proliferation, migration and invasion in nasopharyngeal carcinoma
por: Liu, Haibin, et al.
Publicado: (2019) -
MicroRNA-451 inhibits inflammation and proliferation of glomerular mesangial cells through down-regulating PSMD11 and NF-κB p65
por: Wei, Hua, et al.
Publicado: (2019)